✦ LIBER ✦

Radioimmunoassay of the immunomodulator erythro-9-(2-hydroxy-3-nonyl)-hypoxanthine in human serum and urine

✍ Scribed by E. H. Pfadenhauer; C. E. Jones; K. W. Maxwell

Publisher: John Wiley and Sons
Year: 1983
Tongue: English
Weight: 455 KB
Volume: 72
Category: Article
ISSN: 0022-3549
DOI: 10.1002/jps.2600720818

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Enantiospecific synthesis of the immunop

Enantiospecific synthesis of the immunopotentiators erythro-9 (2-hydroxy-3-nonyl) hypoxanthines and the threo-diastereomers.

✍ M. Bessodes; E. Abushanad; K. Antonakis 📂 Article 📅 1984 🏛 Elsevier Science 🌐 French ⚖ 207 KB

The title compounds were prepared enantiospecifically by kinetic resolution of I+/-) 1-nonene-301 via Sharpless oxidation. The products 1,2R-epoxy-nonane-3S-01 and 1-nonene-3R-ol were efficiently converted to all four stereoisomers of 2-hydroxy-3-nonylamine, which were subsequently incorporated into

High-performance liquid chromatographic

High-performance liquid chromatographic assay for urinary metabolises of a drug after extraction by antiserum to the drug: An example using erythro-9-(2-hydroxy-3-nonyl) hypoxanthine

✍ E.H. Pfadenhauer 📂 Article 📅 1988 🏛 Elsevier Science ⚖ 423 KB

Decreased serum dependence in the growth

Decreased serum dependence in the growth of NIH3T3 cells from the overexpression of human nuclear receptor-binding SET-domain-containing protein 1 (NSD1) or fission yeast su(var)3-9, enhancer-of-zeste, trithorax 2 (SET2)

✍ Toshiko Yamada-Okabe; Naomichi Matsumoto 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

## Abstract Nuclear receptor‐binding SET‐domain‐containing protein 1 (__NSD1__), a culprit gene for Sotos syndrome, contains a su(var)3‐9, enhancer‐of‐zeste, trithorax (SET) domain that is responsible for histone methyltransferase activity and other domains such as plant homeodomain (PHD) and proli

Determination of a new fluoroquinolone a

Determination of a new fluoroquinolone antimicrobial agent, (S)-10-[(S)-(8-amino-6-azaspiro[3,4]octan-6-yl]-9-fluoro-2,3-dihydro-3-methyl-7-oxo-7H-pyrido[1,2,3-de[1,4] benzoxazine-6-carboxylic acid hemihydrate, DV-7751a, in human serum and urine using solid-phase extraction and high-performance liquid chromatography with fluorescence detection

✍ Makoto Tanaka; Yumi Oshima; Hiroyuki Aoki; Hideo Hakusui 📂 Article 📅 1995 🏛 Elsevier Science ⚖ 403 KB